Chargement en cours...

Trials in type 1 diabetes: Antigen-specific therapies

Type 1 diabetes (T1D) results from an aberrant immunological response against the insulin-producing beta cells in the islets of the pancreas. The ideal therapy would restore immune balance in a safe and lasting fashion, stopping the process of beta cell decay. The efficacy of immune suppressive agen...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Immunol
Auteurs principaux: Coppieters, Ken T., Harrison, Leonard C., von Herrath, Matthias G.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777514/
https://ncbi.nlm.nih.gov/pubmed/23490422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!